PillLiraglutide
Brands: Victoza · Liraglutide
8 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it8 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novo Nordisk | unknown | 4 | SUPPLYING |
| A-S Medication Solutions | unknown | 3 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 2 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 2 | SUPPLYING |
| Biocon Pharma Inc | unknown | 2 | SUPPLYING |
| NorthStar Rx LLC | unknown | 2 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 24, 2026RECALLRecall (Class II): Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, …
Presence of particulate matter: a white thread-like structure in the cartridge — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within U.S
- Jul 18, 2023SHORTAGEDrug shortage: Liraglutide Injection (Meitheal Pharmaceuticals, Inc.)
Liraglutide Injection — reported in shortage by Meitheal Pharmaceuticals, Inc.. Therapeutic category: Endocrinology/Metabolism.
- Jul 18, 2023SHORTAGEDrug shortage: Liraglutide Injection (Hikma Pharmaceuticals USA, Inc.)
Liraglutide Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Endocrinology/Metabolism.
- Jul 18, 2023SHORTAGEDrug shortage: Liraglutide Injection (Novo Nordisk, Inc.)
Liraglutide Injection — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
- Mar 22, 2021RECALLRecall (Class II): ViCTOZA (liraglutide) injection, 18 mg/3 mL (6 mg/mL), contains: 1 Victoza Pen, Sample Not for Resale, Rx only, Manufac…
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Recalling firm: Novo Nordisk Inc — Nationwide in the USA